Universal Time: 19:23  |  Local Time: 19:23 (0h GMT)
Select your timezone:



Room: E-Poster Hall

P-12.62 Prognostic analysis of patients underwent salvage liver transplantation within Hangzhou criteria


Prognostic analysis of patients underwent salvage liver transplantation within Hangzhou criteria

Tuo Chen1, Jianhua Li1, Yifeng Tao1, Conghuan Shen1, Zhenyu Ma1, Quanbao Zhang1, Ensi Ma1, Li Li1, Hao Xing1, Linlin Xu1, Zhengxin Wang1.

1General Surgery, Huashan Hospital, Shanghai, People's Republic of China

Objective: To compare the prognosis of patients underwent primary liver transplantation and salvage liver transplantation within Hangzhou criteria, and to evaluate the efficacy of salvage liver transplantation.
Methods: The clinical data of 272 liver cancer patients, who underwent DCD liver transplantation at Huashan Hospital affiliated to Fudan University from May 2014 to October 2019, were retrospectively analyzed. 205 of these patients met the Hangzhou criteria before surgery, including 147 cases were performed primary liver transplantation (PLT) and 58 cases were preformed salvage liver transplantation (SLT). The chi-square test was adopted to compare the postoperative complications and perioperative deaths. Kaplan-Meier curve was plotted according to the follow-up results. In addition, log-rank test was implemented to compare the overall survival rate, as well as the disease-free survival rate between the two groups of subjects.
Results: There were no significant differences in postoperative rejection, biliary complications, vascular complications, and perioperative death between the SLT group and the PLT group (P>0.05). The incidence of postoperative infection in the SLT group was higher than that in the PLT group ( P <0.05). The overall survival rates at 1, 3, and 5 years after surgery in the SLT group were 89.3%, 74.1%, and 74.1% respectively; while those in the PLT group were 83.6%, 80.7%, and 80.7% respectively (P>0.05). The 1-, 3-, and 5-year disease-free survival rates in the SLT group were 80.3%, 64.2%, and 64.2%; and such rates in the PLT group were 91.1%, 84.3%, and 73.8% respectively (P>0.05).
Conclusion: For patients with recurrent liver cancer after hepatectomy that meets the Hangzhou criteria, salvage liver transplantation is a feasible strategy. Patients with salvage liver transplantation need to pay more attention to prevention and the control of postoperative infection.

This study was supported by the grants from the National Science and Technology Major Projects (Nos.2017ZX10203205-002-004 and 2017ZX10203205-003-003) and National Natural Science Foundation of China (Nos.81873874 and8177110753). . .


There are no comments yet...

WebApp Sponsor

© 2024 TTS 2020